scholarly article | Q13442814 |
P2093 | author name string | Gescher A | |
Snowden R | |||
Courage C | |||
P2860 | cites work | Cell cycle arrest and growth inhibition by the protein kinase antagonist UCN-01 in human breast carcinoma cells | Q72078498 |
The role of protein kinase C isoenzymes in the growth inhibition caused by bryostatin 1 in human A549 lung and MCF-7 breast carcinoma cells | Q72253853 | ||
Staurosporine blocks cell progression through G1 between the cyclin D and cyclin E restriction points | Q72522966 | ||
Diverse effects of indolocarbazole compounds on the cell cycle progression of ras-transformed rat fibroblast cells | Q72680385 | ||
The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C | Q28327651 | ||
Potent and specific inhibitors of protein kinase C of microbial origin | Q35307811 | ||
Animal cell cycles and their control | Q35671048 | ||
Signalling targets for anticancer drug development | Q37215680 | ||
Transformed mammalian cells are deficient in kinase-mediated control of progression through the G1 phase of the cell cycle | Q37585411 | ||
Biology of the protein kinase C family | Q38773880 | ||
UCN-01, 7-hydroxyl-staurosporine, inhibits kinase activity of cyclin-dependent kinases and reduces the phosphorylation of the retinoblastoma susceptibility gene product in A549 human lung cancer cell line | Q41226364 | ||
Comparison of ability of protein kinase C inhibitors to arrest cell growth and to alter cellular protein kinase C localisation | Q41354263 | ||
The protein kinase C inhibitor CGP 41251, a staurosporine derivative with antitumor activity, reverses multidrug resistance. | Q41478368 | ||
Selective regulation of expression of protein kinase C (PKC) isoenzymes in multidrug-resistant MCF-7 cells. Functional significance of enhanced expression of PKC alpha. | Q41579047 | ||
Staurosporine is a potent inhibitor of p34cdc2 and p34cdc2-like kinases | Q41628594 | ||
Dianilinophthalimides: potent and selective, ATP-competitive inhibitors of the EGF-receptor protein tyrosine kinase | Q42800011 | ||
A derivative of staurosporine (CGP 41 251) shows selectivity for protein kinase C inhibition and in vitro anti-proliferative as well as in vivo anti-tumor activity | Q44497906 | ||
Antitumor activity of UCN-01, a selective inhibitor of protein kinase C, in murine and human tumor models | Q44781213 | ||
Inhibitors of protein kinase C. 2. Substituted bisindolylmaleimides with improved potency and selectivity | Q57005049 | ||
Highly synchronous culture of fibroblasts from G2 block caused by staurosporine, a potent inhibitor of protein kinases | Q57228862 | ||
Tyrosine kinase activity in breast cancer, benign breast disease, and normal breast tissue | Q69936029 | ||
Antitumor effect of CGP41251, a new selective protein kinase C inhibitor, on human non-small cell lung cancer cells | Q71569301 | ||
Effect of UCN-01, a selective inhibitor of protein kinase C, on the cell-cycle distribution of human epidermoid carcinoma, A431 cells | Q71605859 | ||
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1199-1205 | |
P577 | publication date | 1996-10-01 | |
P1433 | published in | British Journal of Cancer | Q326309 |
P1476 | title | Differential effects of staurosporine analogues on cell cycle, growth and viability in A549 cells | |
P478 | volume | 74 |
Q42538398 | Analogs of staurosporine: potential anticancer drugs? |
Q40771101 | Anti-proliferative effects of new staurosporine derivatives isolated from a marine ascidian and its predatory flatworm |
Q32079496 | Antitumor activity of benzamide riboside and its combination with cisplatin and staurosporine |
Q35143997 | CDK inhibitors in clinical development for the treatment of cancer |
Q28364520 | ColonyArea: an ImageJ plugin to automatically quantify colony formation in clonogenic assays |
Q52183598 | Dysmorphogenic effects of a specific protein kinase C inhibitor during neurulation. |
Q73149086 | Pharmacological inhibition of protein kinase C activity could induce apoptosis in gastric cancer cells by differential regulation of apoptosis-related genes |
Q36075195 | Review of UCN-01 development: a lesson in the importance of clinical pharmacology |
Q40940246 | Screening of five specific cell cycle inhibitors using a T cell lymphoma cell line synchrony/release assay |
Q47927433 | Simultaneous cross-linking of CD6 and CD28 induces cell proliferation in resting T cells |
Q58574978 | Staurosporine Induces the Generation of Polyploid Giant Cancer Cells in Non-Small-Cell Lung Carcinoma A549 Cells |
Q33912029 | Staurosporine analogues - pharmacological toys or useful antitumour agents? |
Q39393487 | Tumor specific cytotoxicity of arctigenin isolated from herbal plant Arctium lappa L. |
Q73905120 | UCN-01 enhances the in vitro toxicity of clinical agents in human tumor cell lines |
Search more.